CN110656167A - Primer group and kit for detecting microdeletion of Y chromosome and detection method based on digital PCR - Google Patents
Primer group and kit for detecting microdeletion of Y chromosome and detection method based on digital PCR Download PDFInfo
- Publication number
- CN110656167A CN110656167A CN201910925088.0A CN201910925088A CN110656167A CN 110656167 A CN110656167 A CN 110656167A CN 201910925088 A CN201910925088 A CN 201910925088A CN 110656167 A CN110656167 A CN 110656167A
- Authority
- CN
- China
- Prior art keywords
- primer
- chromosome
- microdeletion
- detecting
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 55
- 210000002593 Y chromosome Anatomy 0.000 title claims abstract description 31
- 238000007847 digital PCR Methods 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 13
- 210000005259 peripheral blood Anatomy 0.000 claims abstract description 10
- 239000011886 peripheral blood Substances 0.000 claims abstract description 10
- 210000004369 blood Anatomy 0.000 claims abstract description 5
- 239000008280 blood Substances 0.000 claims abstract description 5
- 238000011144 upstream manufacturing Methods 0.000 claims description 24
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000013642 negative control Substances 0.000 claims description 6
- 239000013641 positive control Substances 0.000 claims description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 210000000601 blood cell Anatomy 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 239000008223 sterile water Substances 0.000 claims description 4
- 238000007400 DNA extraction Methods 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 238000003752 polymerase chain reaction Methods 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 206010003883 azoospermia Diseases 0.000 abstract description 4
- 238000007689 inspection Methods 0.000 abstract description 2
- 238000003753 real-time PCR Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 6
- 239000000975 dye Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000011529 RT qPCR Methods 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 231100000535 infertility Toxicity 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000007466 Male Infertility Diseases 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 208000008634 oligospermia Diseases 0.000 description 2
- 230000036616 oligospermia Effects 0.000 description 2
- 231100000528 oligospermia Toxicity 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012356 Product development Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 238000001921 nucleic acid quantification Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009933 reproductive health Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种用于Y染色体微缺失检测的引物组、试剂盒及基于数字PCR的检测方法。本发明针对AZFa亚区sY84和sY86位点,AZFb亚区sY127和sY134位点,AZFc亚区sY254和sY255位点设计了引物组,且其具有高灵敏度、准确客观的优点。本发明提供的检测方法可快速、高灵敏且高准确度地检测无精子症病人的Y染色体微缺失情况,并可有效降低对样本量的要求,从而可将外周血采集进一步降低至指尖血,减小病人痛苦,且可避免病人DNA样本较少时造成的假阴性结果;本发明采用数字PCR方法进行检查,检测结果不依赖于Ct值即可获得,并可直观反映DNA样本的原始拷贝数,从而减少了检测者的工作量。
The invention discloses a primer set, a kit and a detection method based on digital PCR for Y chromosome microdeletion detection. The present invention designs primer sets for the sY84 and sY86 sites of the AZFa subregion, the sY127 and sY134 sites of the AZFb subregion, and the sY254 and sY255 sites of the AZFc subregion, and has the advantages of high sensitivity, accuracy and objectivity. The detection method provided by the present invention can detect the Y chromosome microdeletion of azoospermia patients with high speed, high sensitivity and high accuracy, and can effectively reduce the requirement on the sample volume, so that the peripheral blood collection can be further reduced to fingertip blood , reduce the pain of the patient, and can avoid false negative results when the patient's DNA samples are few; the invention adopts the digital PCR method for inspection, and the detection results can be obtained independently of the Ct value, and can directly reflect the original copy of the DNA sample number, thereby reducing the workload of the inspector.
Description
技术领域technical field
本发明涉及生物检测技术领域,特别涉及一种用于Y染色体微缺失检测的引物组、试剂盒及基于数字PCR的检测方法。The invention relates to the technical field of biological detection, in particular to a primer set, a kit and a detection method based on digital PCR for Y chromosome microdeletion detection.
背景技术Background technique
不孕不育是全球重要的生殖健康问题,大约15%的夫妇会遭遇生育困难或者无法生育的困境,而30%~50%的不育症是由于男性无精或少精等原因引起。当前,男性不育的一个重要原因就是染色体结构异常以及染色体基因的微缺失。临床结果表明,原发性无精和少精症患者中约10%~15%存在Y染色体微缺失,且这一症状可随着辅助生殖技术传递给下一代。因此Y染色体微缺失检测对男性生殖遗传学临床治疗、提高辅助生殖技术的疗效和安全性以及开展胚胎植入前遗传学诊断具有重要意义。Infertility is an important reproductive health problem in the world. About 15% of couples will encounter difficulties in fertility or infertility, while 30% to 50% of infertility is caused by male infertility or oligospermia. At present, an important cause of male infertility is abnormal chromosomal structure and microdeletion of chromosomal genes. Clinical results show that about 10% to 15% of patients with primary azoospermia and oligospermia have Y chromosome microdeletions, and this symptom can be passed on to the next generation with assisted reproductive technology. Therefore, the detection of Y chromosome microdeletion is of great significance for the clinical treatment of male reproductive genetics, improving the efficacy and safety of assisted reproductive technology, and carrying out preimplantation genetic diagnosis.
传统Y染色体微缺失的检测方法主要在PCR技术的基础上展开。国内临床实验室多依据欧洲男科协会(European Academy of Andrology,EAA)和欧洲分子遗传质量协作网(European Molecular Genetics Quality Network,EMQN)提出的方案,采集外周血标本进行多重PCR凝胶电泳、荧光定量(q)PCR以及毛细管电泳等方法进行检测。但这些技术耗时长,结果判定主观性较大,灵敏度较低,不符合目前临床检验技术更快、更灵敏、样品需求更少的发展方向。The traditional detection method of Y chromosome microdeletion is mainly carried out on the basis of PCR technology. Domestic clinical laboratories mostly collect peripheral blood samples for multiplex PCR gel electrophoresis and fluorescence quantification according to the protocols proposed by the European Academy of Andrology (EAA) and the European Molecular Genetics Quality Network (EMQN). (q) PCR and capillary electrophoresis were used for detection. However, these techniques take a long time, the result determination is highly subjective, and the sensitivity is low, which does not conform to the current development direction of faster, more sensitive, and less sample requirements for clinical testing techniques.
数字PCR是20世纪初发展起来的新型核酸定量技术,与传统PCR相比,其可对微量模板进行绝对定量分析,具有更高的准确性、特异性、灵敏性和检测速度。与此同时,数字PCR检测和分析过程自动化程度也比较高,减少了人工结果判定的误差,更减少了荧光定量PCR检测由于低拷贝数检测不到而导致对结果的误判。所以,将数字PCR用于Y染色体微缺失检测是一个研究方向,但现有技术中缺失相关方案。Digital PCR is a new nucleic acid quantification technology developed in the early 20th century. Compared with traditional PCR, it can perform absolute quantitative analysis of trace templates, and has higher accuracy, specificity, sensitivity and detection speed. At the same time, the digital PCR detection and analysis process has a relatively high degree of automation, which reduces the error of manual result judgment, and also reduces the misjudgment of the results due to the low copy number detection caused by the fluorescence quantitative PCR detection. Therefore, the use of digital PCR for Y chromosome microdeletion detection is a research direction, but there are related solutions in the existing technology.
发明内容SUMMARY OF THE INVENTION
本发明所要解决的技术问题在于针对上述现有技术中的不足,提供一种用于Y染色体微缺失检测的引物组、试剂盒及基于数字PCR的检测方法。The technical problem to be solved by the present invention is to provide a primer set, a kit and a detection method based on digital PCR for Y chromosome microdeletion detection in view of the above-mentioned deficiencies in the prior art.
为解决上述技术问题,本发明采用的技术方案是:提供一种用于Y染色体微缺失检测的引物组,包括以下引物组:In order to solve the above-mentioned technical problems, the technical scheme adopted in the present invention is: a primer set for Y chromosome microdeletion detection is provided, including the following primer sets:
用于检测SY84位点的引物对,序列为:The primer pair used to detect the SY84 site, the sequence is:
上游引物AGAAGCGTCTGATAGCAGGT,下游引物GCCTACTACCTGGAGGCTTC;Upstream primer AGAAGCGTCTGATAGCAGGT, downstream primer GCCTACTACCTGGAGGCTTC;
用于检测SY86位点的引物对,序列为:The primer pair used to detect the SY86 site, the sequence is:
上游引物GTGACACACAGACTATGCTTC,下游引物ACACACAGAGTGACAACACT;upstream primer GTGACACACAGACTATGCTTC, downstream primer ACACACAGAGTGACAACACT;
用于检测SY127位点的引物对,序列为:The primer pair used to detect the SY127 site, the sequence is:
上游引物GGCTCACAAACGACGAGAAA,下游引物CTGCAGGCAGTAATAAGTGA;Upstream primer GGCTCACAAACGACGAGAAA, downstream primer CTGCAGGCAGTAATAAGTGA;
用于检测SY134位点的引物对,序列为:The primer pair used to detect the SY134 site, the sequence is:
上游引物GTCTGCCTCACCATATCACG,下游引物ACCACTGCCAAAACTGTCAA;Upstream primer GTTCTGCCTCACCATATCACG, downstream primer ACCACTGCCAAAACTGTCAA;
用于检测SY254位点的引物对,序列为:The primer pair used to detect the SY254 site, the sequence is:
上游引物TGGTGTTACCAGAAGGCAAA,下游引物GAACCGTATCTACCATAGCAGC;Upstream primer TGGTGTTACCAGAAGGCAAA, downstream primer GAACCGTATCTACCATAGCAGC;
用于检测SY255位点的引物对,序列为:The primer pair used to detect the SY255 locus, the sequence is:
上游引物GTTACAGGATTCGGCGTGAT,下游引物CTCGTCATGTGCAGCGAC。Upstream primer GTTACAGGATTCGGCGTGAT, downstream primer CTCGTCATGTGCAGCGAC.
本发明的另一个目的是提供一种用于Y染色体微缺失检测的试剂盒,其包括如上所述的引物组。Another object of the present invention is to provide a kit for Y chromosome microdeletion detection, which includes the primer set as described above.
优选的是,所述试剂盒还包括:PCR预混液、阳性对照、阴性对照和微滴生成油。Preferably, the kit further includes: PCR master mix, positive control, negative control and droplet generation oil.
优选的是,所述PCR预混液包括染料、Taq酶、dNTP、MgCl2。Preferably, the PCR master mix includes dye, Taq enzyme, dNTP, MgCl 2 .
优选的是,所述Taq酶反应浓度为6U,dNTP的反应浓度为0.8mM,MgCl2终浓度为5.6mM。Preferably, the reaction concentration of the Taq enzyme is 6 U, the reaction concentration of dNTP is 0.8 mM, and the final concentration of MgCl 2 is 5.6 mM.
优选的是,所述阳性对照为:健康成年男性的外周血中获得的血细胞DNA,浓度为:10-80ng/ul,所述阴性对照为无菌去离子水。Preferably, the positive control is: blood cell DNA obtained from the peripheral blood of a healthy adult male, the concentration is: 10-80 ng/ul, and the negative control is sterile deionized water.
本发明还提供一种用于Y染色体微缺失检测的基于数字PCR的检测方法,该方法利用如上所述的试剂盒,通过数字PCR的方法,进行Y染色体微缺失检测。The present invention also provides a digital PCR-based detection method for Y chromosome microdeletion detection, which utilizes the above-mentioned kit to perform Y chromosome microdeletion detection by means of digital PCR.
优选的是,本发明的方法包括以下步骤:Preferably, the method of the present invention comprises the following steps:
1)采集待测病人的血液,进行DNA提取,获得待测DNA样本;1) Collect the blood of the patient to be tested, perform DNA extraction, and obtain the DNA sample to be tested;
2)将获得的DNA样品与PCR预混液、引物组、无菌水均匀混合;2) Evenly mix the obtained DNA sample with PCR master mix, primer set and sterile water;
3)将步骤2)得到的混合液生成微滴;3) the mixed solution obtained in step 2) generates droplets;
4)将生成的微滴置于数字PCR扩增仪中进行扩增,获得PCR产品;4) placing the generated droplets in a digital PCR amplifier for amplification to obtain PCR products;
5)使用微滴读数仪对获得的PCR产品进行检测分析。5) Use a droplet reader to detect and analyze the obtained PCR products.
优选的是,所述步骤1)中,待测DNA样本的浓度≥0.0001ng/ul。Preferably, in the step 1), the concentration of the DNA sample to be tested is greater than or equal to 0.0001ng/ul.
优选的是,所述步骤4)中,PCR扩增程序为:酶激活95℃,保持5分钟;然后95℃保持30秒、60℃保持1分钟,并进行40个循环;4℃保持5分钟;90℃保持5分钟。Preferably, in the step 4), the PCR amplification procedure is: the enzyme is activated at 95°C for 5 minutes; then at 95°C for 30 seconds, at 60°C for 1 minute, and performing 40 cycles; at 4°C for 5 minutes ; 90°C for 5 minutes.
本发明的有益效果是:The beneficial effects of the present invention are:
本发明的可快速、高灵敏且高准确度地检测无精子症病人的Y染色体微缺失情况,并可有效降低对样本量的要求,从而可将外周血采集进一步降低至指尖血,减小病人痛苦,且可避免病人DNA样本较少时造成的假阴性结果;The invention can quickly, highly sensitively and accurately detect the Y chromosome microdeletion of azoospermic patients, and can effectively reduce the requirement for sample volume, so that the collection of peripheral blood can be further reduced to fingertip blood. Pain for the patient and avoid false negative results when the patient's DNA sample is small;
本发明采用数字PCR方法进行检查,检测结果不依赖于Ct值即可获得,并可直观反映DNA样本的原始拷贝数,从而减少了检测者的工作量;The invention adopts the digital PCR method for inspection, and the detection result can be obtained independently of the Ct value, and can directly reflect the original copy number of the DNA sample, thereby reducing the workload of the inspector;
本发明获得的试剂盒可在-20℃下稳定保存半年以上,具有良好的产品开发潜质。The kit obtained by the invention can be stably stored at -20° C. for more than half a year, and has good product development potential.
附图说明Description of drawings
图1为本发明的实施例2中AZFb缺失病人外周血样本的检测结果示意图;1 is a schematic diagram of the detection results of peripheral blood samples of AZFb-deficient patients in Example 2 of the present invention;
图2为本发明的实施例2中AZFb缺失样本进行荧光定量PCR检测的结果示意图;FIG. 2 is a schematic diagram of the results of fluorescence quantitative PCR detection of AZFb deletion samples in Example 2 of the present invention;
图3a、3b、3c分别为本发明的实施例3中采用荧光定量PCR方法检测浓度依次为10ng/ul、1ng/ul、0.1ng/ul的样本的结果图;Figures 3a, 3b, and 3c are respectively the result diagrams of samples with a concentration of 10ng/ul, 1ng/ul, and 0.1ng/ul detected by the fluorescence quantitative PCR method in Example 3 of the present invention;
图4a、4b、4c为本发明的实施例3中采用基于数字PCR的检测方法检测浓度依次为0.001ng/ul、0.0001ng/ul、0.00001ng/ul的样本的结果图。Figures 4a, 4b, and 4c are the results of detecting samples with concentrations of 0.001 ng/ul, 0.0001 ng/ul, and 0.00001 ng/ul in sequence by using the digital PCR-based detection method in Example 3 of the present invention.
具体实施方式Detailed ways
下面结合实施例对本发明做进一步的详细说明,以令本领域技术人员参照说明书文字能够据以实施。The present invention will be further described in detail below with reference to the embodiments, so that those skilled in the art can implement according to the description.
应当理解,本文所使用的诸如“具有”、“包含”以及“包括”术语并不排除一个或多个其它元件或其组合的存在或添加。It should be understood that terms such as "having", "comprising" and "including" as used herein do not exclude the presence or addition of one or more other elements or combinations thereof.
实施例1Example 1
设计一种用于Y染色体微缺失检测的引物组,用以检测AZFa亚区sY84和sY86位点,AZFb亚区sY127和sY134位点,AZFc亚区sY254和sY255位点的基因缺失,其具体包括以下引物组合:A primer set for Y chromosome microdeletion detection was designed to detect gene deletions at sites sY84 and sY86 in the AZFa subregion, sY127 and sY134 in the AZFb subregion, and sY254 and sY255 in the AZFc subregion. The following primer combinations:
用于检测SY84位点的引物对,序列为:The primer pair used to detect the SY84 site, the sequence is:
上游引物AGAAGCGTCTGATAGCAGGT,下游引物GCCTACTACCTGGAGGCTTC;Upstream primer AGAAGCGTCTGATAGCAGGT, downstream primer GCCTACTACCTGGAGGCTTC;
用于检测SY86位点的引物对,序列为:The primer pair used to detect the SY86 site, the sequence is:
上游引物GTGACACACAGACTATGCTTC,下游引物ACACACAGAGTGACAACACT;upstream primer GTGACACACAGACTATGCTTC, downstream primer ACACACAGAGTGACAACACT;
用于检测SY127位点的引物对,序列为:The primer pair used to detect the SY127 site, the sequence is:
上游引物GGCTCACAAACGACGAGAAA,下游引物CTGCAGGCAGTAATAAGTGA;Upstream primer GGCTCACAAACGACGAGAAA, downstream primer CTGCAGGCAGTAATAAGTGA;
用于检测SY134位点的引物对,序列为:The primer pair used to detect the SY134 site, the sequence is:
上游引物GTCTGCCTCACCATATCACG,下游引物ACCACTGCCAAAACTGTCAA;Upstream primer GTTCTGCCTCACCATATCACG, downstream primer ACCACTGCCAAAACTGTCAA;
用于检测SY254位点的引物对,序列为:The primer pair used to detect the SY254 site, the sequence is:
上游引物TGGTGTTACCAGAAGGCAAA,下游引物GAACCGTATCTACCATAGCAGC;Upstream primer TGGTGTTACCAGAAGGCAAA, downstream primer GAACCGTATCTACCATAGCAGC;
用于检测SY255位点的引物对,序列为:The primer pair used to detect the SY255 locus, the sequence is:
上游引物GTTACAGGATTCGGCGTGAT,下游引物CTCGTCATGTGCAGCGAC。Upstream primer GTTACAGGATTCGGCGTGAT, downstream primer CTCGTCATGTGCAGCGAC.
上述引物组合具有与Y染色体微缺失的6个位点有及其强的互补配对性质,确保目标位点的准确性。The above primer combination has strong complementary pairing properties with the 6 sites of the Y chromosome microdeletion, ensuring the accuracy of the target site.
实施例2Example 2
构建一种用于Y染色体微缺失检测的试剂盒,该试剂盒包括实施例1所述的引物组。进一步优选的实施例中,所述试剂盒还包括:PCR预混液、阳性对照、阴性对照和微滴生成油。A kit for Y chromosome microdeletion detection was constructed, the kit including the primer set described in Example 1. In a further preferred embodiment, the kit further includes: PCR master mix, positive control, negative control and droplet generation oil.
其中,所述PCR预混液包括染料、Taq酶、dNTP、MgCl2。更具体的,染料为:EvaGreen染料2x(20x EvaGreen染料稀释10倍)0,所述Taq酶反应浓度为6U,dNTP的反应浓度为0.8mM,MgCl2终浓度为5.6mM。Wherein, the PCR premix solution includes dye, Taq enzyme, dNTP, MgCl 2 . More specifically, the dyes are: EvaGreen dye 2x (20x EvaGreen dye diluted 10 times) 0, the reaction concentration of Taq enzyme is 6U, the reaction concentration of dNTP is 0.8mM, and the final concentration of MgCl2 is 5.6mM.
其中,所述阳性对照为:健康成年男性的外周血中获得的血细胞DNA,浓度为:10-80ng/ul,所述阴性对照为无菌去离子水(不含有DNA和RNA)。Wherein, the positive control is blood cell DNA obtained from the peripheral blood of healthy adult males, and the concentration is 10-80 ng/ul, and the negative control is sterile deionized water (without DNA and RNA).
微滴生成油,QX200 Droplet Generation Oil for EvaGreen,购自美国伯乐公司。The droplet generation oil, QX200 Droplet Generation Oil for EvaGreen, was purchased from Bole Corporation, USA.
实施例3Example 3
提供一种用于Y染色体微缺失检测的基于数字PCR的检测方法,该方法利用实施例2获得的试剂盒,通过数字PCR的方法,进行Y染色体微缺失检测。其具体包括以下步骤:A digital PCR-based detection method for Y chromosome microdeletion detection is provided. The method utilizes the kit obtained in Example 2 to perform Y chromosome microdeletion detection by means of digital PCR. It specifically includes the following steps:
1)采集待测病人的外周血或指尖血,体积范围:50μl-500μl,可采用通用核酸柱式抽提试剂盒(上海生工,B518253-0050)进行DNA提取,所获得DNA经紫外(260nm)吸收检测获得浓度及纯度,获得待测DNA样本,其浓度≥0.0001ng/ul;1) Collect peripheral blood or fingertip blood of the patient to be tested, the volume range: 50μl-500μl, DNA extraction can be carried out using a universal nucleic acid column extraction kit (Shanghai Sangong, B518253-0050), and the obtained DNA is subjected to ultraviolet ( 260nm) absorption detection to obtain concentration and purity, to obtain DNA samples to be tested, the concentration of which is ≥ 0.0001ng/ul;
2)将获得的DNA样品与PCR预混液、引物组、无菌水均匀混合,体积分别为10ul PCR预混液、0.4ul引物组(10uM)、2ul DNA提取液为、7.2ul无菌水为,旋涡混匀后保持在4℃待用;2) Evenly mix the obtained DNA sample with PCR premix, primer set and sterile water, and the volumes are respectively 10ul PCR premix, 0.4ul primer set (10uM), 2ul DNA extract, 7.2ul sterile water, Vortex to mix and keep at 4°C until use;
3)将步骤2)得到的混合液生成微滴,具体为:3) The mixed solution obtained in step 2) generates droplets, specifically:
将微滴生成卡放入座,向中间一排细孔中每孔加入20ul反应体系;将微滴生成油70ul每孔加入生成卡最下面一排;在卡座上装好密封垫后,放入微滴生成仪;微滴生成结束后,缓慢从最上面一排孔中吸出微滴转移到八连管中;如图,为微滴生成卡,微滴生成油加到最下面一排,混合均匀的待测液加到中间一排,在微滴生成仪生成之后,生成的微滴在最上面一排,温和地将生成好的微滴转移到八连管当中,进行后续操作;Put the droplet generation card into the holder, and add 20ul reaction system to each hole in the middle row of pores; add 70ul of microdroplet generation oil to each hole in the bottom row of the generation card; after installing the gasket on the card holder, put it in Droplet generator; after the droplet generation is completed, slowly suck out the droplets from the top row of holes and transfer them to the eight-connected tube; as shown in the figure, it is the droplet generation card, and the droplet generation oil is added to the bottom row and mixed. The uniform liquid to be tested is added to the middle row. After the droplet generator is generated, the generated droplets are in the top row, and the generated droplets are gently transferred to the eight-connected tube for subsequent operations;
4)将生成的微滴置于数字PCR扩增仪中进行扩增,PCR扩增程序为:酶激活95℃,保持5分钟;然后95℃保持30秒、60℃保持1分钟,并进行40个循环;信号稳定4℃保持5分钟;90℃保持5分钟;获得PCR产品;4) Place the generated droplets in a digital PCR amplifier for amplification. The PCR amplification procedure is as follows: the enzyme is activated at 95°C and kept for 5 minutes; then kept at 95°C for 30 seconds, 60°C for 1 minute, and performed for 40 minutes. cycle; the signal is stable at 4°C for 5 minutes; at 90°C for 5 minutes; PCR products are obtained;
5)使用微滴读数仪对获得的PCR产品进行检测分析:将八联管盖子去掉,放入微滴读数仪器内,扣上固定锁扣,关闭舱门;设置实验参数、样本名称和目标物名称,Supermix选择EvaGreen;运行程序进行检测。检测结果如图1和2所示。图1为AZFb缺失病人外周血样本的检测结果,其中的待测DNA样本的浓度为0.0001ng/ul。图2为AZFb缺失样本进行荧光定量PCR检测的结果,图中AZFb为两条直线。5) Use the droplet reader to detect and analyze the obtained PCR products: remove the cap of the eight-tube tube, put it into the droplet reader, fasten the fixed lock, and close the hatch; set the experimental parameters, sample name and target Name, Supermix chooses EvaGreen; run the program to detect. The test results are shown in Figures 1 and 2. Figure 1 shows the detection results of peripheral blood samples from patients with AZFb deletion, where the concentration of the DNA samples to be tested is 0.0001 ng/ul. Figure 2 shows the results of fluorescence quantitative PCR detection of AZFb-deficient samples, and AZFb in the figure is two straight lines.
本发明的检测方法相对于常规荧光定量PCR而言,可直观反映DNA样本的原始拷贝数,从而减少了检测者的工作量,并且检测限更低,具有更高的灵敏度。在本实施例中进行了采用常规荧光定量PCR与本发明的基于数字PCR的检测方法的比较。其中,两者方法均采用实施例2获得的试剂盒。其中的待测DNA样本均相同,为健康成年男性的外周血中获得的血细胞DNA,即Y染色体不存在缺失。Compared with the conventional fluorescent quantitative PCR, the detection method of the present invention can directly reflect the original copy number of the DNA sample, thereby reducing the workload of the detector, and has lower detection limit and higher sensitivity. In this example, a comparison between the conventional fluorescent quantitative PCR and the digital PCR-based detection method of the present invention is carried out. Wherein, both methods use the kit obtained in Example 2. The DNA samples to be tested are all the same, and are blood cell DNA obtained from the peripheral blood of healthy adult males, that is, there is no deletion of the Y chromosome.
参照图3a、3b、3c,均采用荧光定量PCR方法,待测DNA样本的浓度依次为10ng/ul、1ng/ul、0.1ng/ul,然后根据目前对qPCR(荧光定量PCR)的测试的水平,基本在Ct32之前没有成功起跳就算是没有目标基因的存在,从图中可以看出,浓度为10ng/ul、1ng/ul时,Ct32之前成功起跳,可实现检测,浓度0.1ng/ul时,没有成功,无法实现检测,所以此实施例中,qPCR的检测下限为0.1ng/ul。Referring to Figures 3a, 3b, and 3c, the fluorescence quantitative PCR method is used, and the concentration of the DNA sample to be tested is 10ng/ul, 1ng/ul, 0.1ng/ul in turn, and then according to the current level of qPCR (fluorescence quantitative PCR) testing , basically if the target gene does not successfully take off before Ct32, it can be seen from the figure that when the concentration is 10ng/ul and 1ng/ul, Ct32 successfully takes off before, and the detection can be realized. When the concentration is 0.1ng/ul, the Without success, the detection could not be achieved, so in this example, the detection limit of qPCR was 0.1 ng/ul.
参照图4a、4b、4c,均采用发明的基于数字PCR的检测方法,待测DNA样本的浓度依次为0.001ng/ul、0.0001ng/ul、0.00001ng/ul,从图中可以看出,0.0001ng/ul时仍能检测到结果,0.00001ng/ul时存在AZFb位点未检测到结果,所以该方法检测限能达到0.0001ng/ul,远远低于qPCR的0.1ng/ul,能突显本发明的检测方法的高灵敏度的优势。Referring to Figures 4a, 4b, and 4c, the invented detection method based on digital PCR is adopted, and the concentration of the DNA sample to be tested is 0.001ng/ul, 0.0001ng/ul, 0.00001ng/ul in sequence. It can be seen from the figure that 0.0001 The results can still be detected at 0.00001ng/ul, and the AZFb site can not be detected at 0.00001ng/ul, so the detection limit of this method can reach 0.0001ng/ul, which is much lower than 0.1ng/ul of qPCR, which can highlight the Advantages of the high sensitivity of the inventive detection method.
尽管本发明的实施方案已公开如上,但其并不仅仅限于说明书和实施方式中所列运用,它完全可以被适用于各种适合本发明的领域,对于熟悉本领域的人员而言,可容易地实现另外的修改,因此在不背离权利要求及等同范围所限定的一般概念下,本发明并不限于特定的细节。Although the embodiment of the present invention has been disclosed as above, it is not limited to the application listed in the description and the embodiment, and it can be applied to various fields suitable for the present invention. For those skilled in the art, it can be easily Therefore, the invention is not limited to the specific details without departing from the general concept defined by the appended claims and the scope of equivalents.
发明名称:用于y染色体微缺失检测的引物组、试剂盒及基于数字pcr的检测方法Invention Title: Primer set, kit and digital PCR-based detection method for y chromosome microdeletion detection
用于检测SY84位点的引物对,序列为:The primer pair used to detect the SY84 site, the sequence is:
上游引物AGAAGCGTCTGATAGCAGGT,下游引物GCCTACTACCTGGAGGCTTC。Upstream primer AGAAGCGTCTGATAGCAGGT, downstream primer GCCTACTACCTGGAGGCTTC.
用于检测SY86位点的引物对,序列为:The primer pair used to detect the SY86 site, the sequence is:
上游引物GTGACACACAGACTATGCTTC,下游引物ACACACAGAGTGACAACACT。Upstream primer GTGACACACAGACTATGCTTC, downstream primer AACACACAGAGTGACAACACT.
用于检测SY127位点的引物对,序列为:The primer pair used to detect the SY127 site, the sequence is:
上游引物GGCTCACAAACGACGAGAAA,下游引物CTGCAGGCAGTAATAAGTGA。Upstream primer GGCTCACAAACGACGAGAAA, downstream primer CTGCAGGCAGTAATAAGTGA.
用于检测SY134位点的引物对,序列为:The primer pair used to detect the SY134 site, the sequence is:
上游引物GTCTGCCTCACCATATCACG,下游引物ACCACTGCCAAAACTGTCAA。Upstream primer GTCTGCCTCACCATATCACG, downstream primer ACCACTGCCAAAACTGTCAA.
用于检测SY254位点的引物对,序列为:The primer pair used to detect the SY254 site, the sequence is:
上游引物TGGTGTTACCAGAAGGCAAA,下游引物GAACCGTATCTACCATAGCAGC。Upstream primer TGGTGTTACCAGAAGGCAAA, downstream primer GAACCGTATCTACCATAGCAGC.
用于检测SY255位点的引物对,序列为:The primer pair used to detect the SY255 locus, the sequence is:
上游引物GTTACAGGATTCGGCGTGAT,下游引物CTCGTCATGTGCAGCGAC。Upstream primer GTTACAGGATTCGGCGTGAT, downstream primer CTCGTCATGTGCAGCGAC.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910925088.0A CN110656167A (en) | 2019-09-27 | 2019-09-27 | Primer group and kit for detecting microdeletion of Y chromosome and detection method based on digital PCR |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910925088.0A CN110656167A (en) | 2019-09-27 | 2019-09-27 | Primer group and kit for detecting microdeletion of Y chromosome and detection method based on digital PCR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110656167A true CN110656167A (en) | 2020-01-07 |
Family
ID=69039480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910925088.0A Pending CN110656167A (en) | 2019-09-27 | 2019-09-27 | Primer group and kit for detecting microdeletion of Y chromosome and detection method based on digital PCR |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110656167A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102703578A (en) * | 2011-07-06 | 2012-10-03 | 郭奇伟 | Multiple real-time fluorescent PCR detection kit for Y chromosome microdeletion |
| CN108048552A (en) * | 2017-12-19 | 2018-05-18 | 益善生物技术股份有限公司 | It is a kind of to be used to detect the micro-deleted Nucleic acid combinations of Y chromosome and kit and application |
| CN108697068A (en) * | 2015-09-17 | 2018-10-23 | 瑞泽恩制药公司 | Selection of pluripotent cells for generation of fertile XY female mice |
| WO2019033065A1 (en) * | 2017-08-11 | 2019-02-14 | Atila Biosystems, Inc. | Digital amplification with primers of limited nucleotide composition |
-
2019
- 2019-09-27 CN CN201910925088.0A patent/CN110656167A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102703578A (en) * | 2011-07-06 | 2012-10-03 | 郭奇伟 | Multiple real-time fluorescent PCR detection kit for Y chromosome microdeletion |
| CN108697068A (en) * | 2015-09-17 | 2018-10-23 | 瑞泽恩制药公司 | Selection of pluripotent cells for generation of fertile XY female mice |
| WO2019033065A1 (en) * | 2017-08-11 | 2019-02-14 | Atila Biosystems, Inc. | Digital amplification with primers of limited nucleotide composition |
| CN108048552A (en) * | 2017-12-19 | 2018-05-18 | 益善生物技术股份有限公司 | It is a kind of to be used to detect the micro-deleted Nucleic acid combinations of Y chromosome and kit and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112063756B (en) | Method and kit for multiple detection of respiratory virus nucleic acid | |
| CN110273027B (en) | Nucleic acid typing detection kit and detection method for norovirus GII, GII and GIV | |
| CN108048548A (en) | People's spinal muscular atrophy Disease-causing gene copy number detects PCR kit for fluorescence quantitative | |
| CN111286560A (en) | Internal reference gene for PCR detection of respiratory RNA virus and its detection product | |
| CN106167833A (en) | A kind of detection RT PCR primer of 8 kinds of entomophila encephalitises simultaneously and probe combinations and test kit | |
| Kim et al. | A CRISPR/Cas12 trans-cleavage reporter enabling label-free colorimetric detection of SARS-CoV-2 and its variants | |
| CN113136418B (en) | Composition of primer and probe for detecting microdeletion of Y chromosome, detection method and kit for non-diagnosis purpose | |
| CN105018488B (en) | Kit for detecting respiratory virus and its application | |
| CN106148484B (en) | A kind of kit that diagnosis Y chromosome is micro-deleted | |
| CN110029171B (en) | A kit for detecting PIK3CA gene mutation sites using stem-loop primers | |
| CN110938680A (en) | Gene variation site detection method for simultaneously detecting DNA and RNA | |
| CN109517928B (en) | Triple fluorescent quantitative PCR detection kit for hepatitis B virus miR-3 and human liver specificity miR-122 | |
| CN109321651A (en) | A kind of composition, kit, sample treatment and application detecting people CYP2D6 gene pleiomorphism | |
| CN108342473A (en) | It is a kind of to be used to detect the kit that blood lipid metabolism related gene ABCG1 methylates | |
| CN104774918A (en) | IL28B gene polymorphism detection kit based on real-time fluorescent PCR | |
| CN104087672A (en) | Kit for quickly detecting number of human chromosomes 21 by multiplex real-time fluorescence quantitative PCR (polymerase chain reaction) technique | |
| CN110656167A (en) | Primer group and kit for detecting microdeletion of Y chromosome and detection method based on digital PCR | |
| CN109182494B (en) | Gene chip and kit for noninvasive prenatal assessment of hemifacial shortness syndrome and application method of gene chip | |
| CN112981007A (en) | Kit for detecting Han beach type hantavirus and detection method thereof | |
| WO2020134950A1 (en) | Gene mutation/fusion combination and kit for identification of benign and malignant pulmonary nodules | |
| CN111718993B (en) | A double fluorescence quantitative PCR detection kit for human serum miR-146a and its application | |
| CN116769918A (en) | Marker for evaluating risk of colon adenocarcinoma | |
| CN116949212A (en) | A primer set, kit and application for detecting infectious disease pathogens | |
| CN109628559A (en) | A kind of method and kit of detection Y chromosome copy number variation | |
| CN100436598C (en) | Biological articles for detecting hepatitis B virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200107 |
|
| RJ01 | Rejection of invention patent application after publication |